CN Stock MarketDetailed Quotes
002644 Lanzhou Foci Pharmaceutical
- 7.68
- 0.000.00%
Not Open Jan 15 09:30 CST
3.92BMarket Cap85.33P/E (TTM)
0.00High0.00Low0lotVolume0.00Open7.68Pre Close0.00Turnover0.00%Turnover Ratio58.18P/E (Static)510.66MShares9.9152wk High2.22P/B3.92BFloat Cap5.8152wk Low8.45Limit Up510.66MShs Float26.88Historical High6.91Limit Down0.00%Amplitude2.15Historical Low0.03Dividend TTM--Avg Price0lotAsk0.39%Div YieldTTM100Lot Size0lotBid
Lanzhou Foci Pharmaceutical Key Stats
All
YOY
| (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | -19.75%708.53M | -20.26%498.88M | -13.85%274.33M | 11.58%1.16B | 26.42%882.92M | 35.49%625.66M | 34.43%318.45M | 27.49%1.04B | 5.16%698.41M | 19.38%461.79M |
| Operating revenue | -19.75%708.53M | -20.26%498.88M | -13.85%274.33M | 11.58%1.16B | 26.42%882.92M | 35.49%625.66M | 34.43%318.45M | 27.49%1.04B | 5.16%698.41M | 19.38%461.79M |
| Other operating revenue | ---- | 34.60%1.73M | ---- | 244.39%5.45M | ---- | -12.14%1.29M | ---- | -80.83%1.58M | ---- | -73.75%1.47M |
| Total operating cost | -20.99%651.59M | -20.96%449.71M | -15.81%245.79M | 13.57%1.08B | 27.28%824.71M | 39.11%568.96M | 38.04%291.95M | 26.21%950.2M | 6.35%647.96M | 15.25%409M |
| Operating cost | -22.45%481.63M | -21.47%334.87M | -17.83%189.02M | 8.77%801.84M | 24.56%621.04M | 36.13%426.42M | 37.93%230.04M | 24.00%737.18M | 6.80%498.61M | 10.46%313.25M |
| Operating tax surcharges | 5.65%10M | 1.43%6.56M | 29.16%3.57M | -8.24%13.36M | 2.01%9.46M | -2.27%6.47M | -12.13%2.76M | -1.73%14.56M | -10.10%9.28M | -1.28%6.62M |
| Operating expense | -19.42%93.06M | -25.43%61.68M | -13.29%27.98M | 33.79%153.73M | 35.77%115.48M | 53.24%82.71M | 26.14%32.27M | 41.39%114.9M | -9.65%85.06M | 32.83%53.97M |
| Administration expense | -19.79%49.5M | -15.72%34.63M | -13.36%18.77M | 24.64%84.29M | 34.14%61.71M | 36.08%41.09M | 66.63%21.67M | 30.60%67.63M | 31.81%46M | 31.41%30.19M |
| Financial expense | -2.58%-4.36M | -0.34%-2.65M | 58.87%-446.91K | 34.72%-4.97M | 20.17%-4.25M | 27.22%-2.64M | -5.22%-1.09M | 13.62%-7.62M | 28.95%-5.32M | 33.89%-3.63M |
| -Interest expense (Financial expense) | -41.67%973.58K | -41.45%415.45K | ---- | -8.10%1.24M | --1.67M | -27.09%709.58K | ---- | 42.79%1.35M | ---- | 97.71%973.19K |
| -Interest Income (Financial expense) | -4.47%-5.45M | 12.26%-3.1M | ---- | 28.55%-5.37M | ---5.21M | 24.49%-3.54M | ---- | 26.36%-7.51M | ---- | 22.28%-4.68M |
| Research and development | 2.36%21.77M | -1.93%14.62M | 9.37%6.89M | 31.29%30.93M | 48.27%21.27M | 73.54%14.91M | 56.43%6.3M | 21.69%23.56M | 36.02%14.34M | 32.71%8.59M |
| Credit Impairment Loss | -724.10%-21.14M | -497.19%-13.81M | -345.87%-8M | 37.23%-14.64M | 110.93%3.39M | 271.99%3.48M | 54.89%-1.79M | -110.31%-23.32M | 856.25%1.61M | 174.62%934.64K |
| Asset Impairment Loss | -108.02%-17.69K | -107.79%-17.69K | --0 | -737.48%-1.06M | --220.64K | --227.14K | -409.83%-227.14K | 57.76%-126.3K | ---- | ---- |
| Other net revenue | -156.61%-10.63M | -147.48%-6.92M | -251.82%-5.54M | -101.35%-689.03K | 20.24%18.77M | 67.17%14.57M | 1,662.83%3.65M | 7.01%50.95M | -44.96%15.61M | -59.74%8.71M |
| Invest income | -646.73%-6.52M | -333.26%-3.41M | -525.78%-2.61M | -246.29%-4.49M | 134.85%1.19M | 153.89%1.46M | --612.81K | -68.76%-1.3M | -372.24%-3.42M | -339.55%-2.71M |
| -Including: Investment income associates | -648.87%-6.56M | -338.27%-3.45M | -525.78%-2.61M | -14.14%-4.56M | --1.19M | --1.45M | --612.81K | -105.64%-4M | ---- | ---- |
| Asset deal income | --11.68K | --11.68K | --175.71 | ---- | ---- | ---- | --0 | -100.00%704.87 | ---- | ---- |
| Other revenue | 21.98%17.04M | 9.71%10.31M | 0.04%5.06M | -74.24%19.5M | -19.84%13.97M | -10.43%9.4M | 23.12%5.06M | 131.73%75.7M | -34.55%17.43M | -51.95%10.49M |
| Operating profit | -39.83%46.32M | -40.71%42.26M | -23.72%23M | -41.82%83.27M | 16.52%76.98M | 15.88%71.27M | 17.84%30.15M | 27.40%143.14M | -20.65%66.06M | 14.80%61.5M |
| Add:Non operating Income | -49.05%32.96K | -92.48%4.38K | -89.68%4.22K | -36.83%116.42K | -76.42%64.69K | -71.93%58.23K | -26.17%40.92K | 132.19%184.29K | -27.66%274.34K | -38.75%207.49K |
| Less:Non operating expense | -33.33%679.81K | -53.50%470.84K | 595.80%400.83K | -86.13%1.75M | -80.05%1.02M | -65.88%1.01M | 691.31%57.61K | 675.14%12.61M | 5,484.58%5.11M | 1,753.72%2.97M |
| Total profit | -39.92%45.67M | -40.57%41.79M | -25.00%22.6M | -37.54%81.64M | 24.17%76.02M | 19.70%70.32M | 17.55%30.14M | 17.96%130.72M | -26.71%61.22M | 9.28%58.74M |
| Less:Income tax cost | -66.03%5.22M | -61.51%4.73M | -36.43%3.96M | -36.73%13.52M | 91.49%15.37M | 67.36%12.28M | 52.35%6.23M | 23.54%21.37M | -36.88%8.03M | 16.22%7.34M |
| Net profit | -33.30%40.45M | -36.13%37.06M | -22.01%18.64M | -37.70%68.12M | 14.01%60.65M | 12.90%58.03M | 10.95%23.9M | 16.93%109.35M | -24.88%53.19M | 8.35%51.4M |
| Net profit from continuing operation | -33.30%40.45M | -36.13%37.06M | -22.01%18.64M | -37.70%68.12M | 14.01%60.65M | 12.90%58.03M | --23.9M | 16.93%109.35M | -24.88%53.19M | 8.35%51.4M |
| Less:Minority Profit | 145.73%1.38M | 264.38%968.58K | 2,360.15%254.35K | 34.40%932.29K | 77.02%559.86K | 60.71%265.82K | -123.04%-11.25K | 168.11%693.66K | 803.31%316.27K | 214.68%165.4K |
| Net profit of parent company owners | -34.97%39.07M | -37.52%36.1M | -23.11%18.39M | -38.16%67.19M | 13.63%60.09M | 12.74%57.77M | 11.25%23.92M | 16.51%108.65M | -25.29%52.88M | 7.68%51.24M |
| Earning per share | ||||||||||
| Basic earning per share | -35.00%0.0765 | -37.49%0.0707 | -23.08%0.036 | -38.16%0.1316 | 13.72%0.1177 | 12.31%0.1131 | 11.16%0.0468 | 16.54%0.2128 | -25.32%0.1035 | 8.40%0.1007 |
| Diluted earning per share | -35.00%0.0765 | -37.49%0.0707 | -23.08%0.036 | -38.16%0.1316 | 13.72%0.1177 | 12.31%0.1131 | 11.16%0.0468 | 16.54%0.2128 | -25.32%0.1035 | 8.40%0.1007 |
| Other composite income | 1,166.78%487.79K | 938.09%496.37K | -191.29%-241.98K | -20.04%38.51K | 87.84%47.82K | 3,125.98%265.07K | 48.16K | 25.46K | ||
| Other composite income of parent company owners | 1,094.39%251.52K | 878.77%255.94K | ---- | -191.29%-132.33K | -16.67%21.06K | 87.84%26.15K | ---- | 1,664.21%144.96K | --25.27K | --13.92K |
| Other composite income of minority owners | 1,254.14%236.28K | 1,009.68%240.43K | ---- | -191.29%-109.65K | -23.77%17.45K | 87.84%21.67K | ---- | --120.11K | --22.89K | --11.53K |
| Total composite income | -32.54%40.94M | -35.33%37.56M | -22.01%18.64M | -38.07%67.88M | 13.98%60.68M | 12.94%58.08M | 10.95%23.9M | 17.20%109.61M | -24.81%53.24M | 8.41%51.43M |
| Total composite income of parent company owners | -34.58%39.32M | -37.10%36.35M | -23.11%18.39M | -38.37%67.06M | 13.62%60.11M | 12.76%57.79M | 11.25%23.92M | 16.65%108.8M | -25.25%52.9M | 7.71%51.25M |
| Total composite income of minority owners | 179.23%1.61M | 320.55%1.21M | 2,360.15%254.35K | 1.09%822.64K | 70.21%577.31K | 62.48%287.49K | -123.04%-11.25K | 214.53%813.77K | 868.68%339.16K | 222.68%176.94K |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Lianda Certified Public Accountants (Special General Partnership) | -- | -- | -- | Lianda Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Heat List
CN
Overall
Symbol
Price
% Chg
No Data
